A Novel Nomogram to Predict the Probability of Prostate Cancer on Repeat Biopsy

Journal of Urology

Volumn 180, Issue 1, 2008, Pages 146-149

  Benecchi, Luigi ^a   Pieri, Anna Maria ^a   Melissari, Massimo ^a   Potenzoni, Michele ^a   Pastizzaro, Carmelo Destro ^a  

^a Fidenza Hospital   (Italy)

Author keywords

biopsy; nomograms; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; PRIORITY JOURNAL; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; STATISTICAL SIGNIFICANCE; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS;

EID: 44649176942     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.03.043     Document Type: Article

References (15)

1. Kirby S.R., Christmas T.J., and Brawer M.K. Prostate Cancer. 2nd ed. (2001), Mosby, London
2. Catalona W.J., Smith D.S., and Ratliff T.L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156
3. Puppo P. Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. Eur Urol 52 (2007) 639
4. Karakiewicz P.I., Benayoun S., Kattan M.W., Perrotte P., Valiquette L., Scardion P.T., et al. Development and validation of a nomogram predicting the out-come of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930
5. Chun F.K.H., Briganti A., Graefen M., Montorsi F., Porter C., Scattoni V., et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 52 (2007) 436
6. Benecchi L. Neuro-Fuzzy System for prostate cancer diagnosis. Urology 68 (2006) 357
7. Khan M.A., Carter H.B., Epstein J.I., Miller M.C., Landis P., Walsh P.W., et al. Can prostate specific antigen derivates and pathological parameters predict significant change in expectant management criteria for prostate cancer?. J Urol 170 (2003) 2274
8. Benecchi L. PSA slope and PSA velocity. Prostate Cancer Prostatic Dis 9 (2006) 169
9. Chun F.K., Karakiewicz P.I., Briganti A., Gallina A., Kattan M.W., Montorsi F., et al. Prostate cancer nomograms: an update. Eur Urol 50 (2006) 914
10. Lopez-Corona E., Ohori M., Scardino P.T., Reuter V.E., Gonen M., and Kattan M.W. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 170 (2003) 1184
11. Yanke B.V., Gonen M., Scardino P.T., and Kattan M.W. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 173 (2005) 421
12. Walz J., Graefen M., Chun F.K., Erbersdobler A., Haese A., Steuber T., et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50 (2006) 498
13. Takamiya R., Weinberg V., Young D., Sandler H., McLaughlin P., and Roach M. A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer. Int J Radiation Oncology Biol Phys 56 (2003) 1073
14. Wagner M.D., Daneshmand S., Sokoloff M., and Barry J.M. Re: prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. J Urol 177 (2007) 2396
15. Epstein J.I., and Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175 (2006) 820